Sept 23 (Reuters) - ESSA Pharma Inc EPI.TO :
* Receives FDA approval to commence clinical development
* Intends to seek approval from the health protection branch in Canada to
include Canadian sites in the phase 1/2 study
* Says enrolment in the clinical trial is expected to commence in the next few
weeks
* Sees approval of IND application to trigger an additional $3.7 million of
funding from the Cancer Prevention and Research Institute of Texas
* Says plans to file a clinical trial authorization application with the HPB in
order to obtain that approval
* Source text for Eikon ID:nPn5qYGFS
* Further company coverage EPI.TO